UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prolonged administration of maraviroc reactivates latent HIV in vivo but it does not prevent antiretroviral-free viral rebound

Scientific reports, 2020-12, Vol.10 (1), p.22286-22286, Article 22286

2020

Volltextzugriff (PDF)

Potential healthcare resource use and associated costs of every 2 month injectable cabotegravir plus rilpivirine long-acting regimen implementation in the Spanish National Healthcare System compared to daily oral HIV treatments

BMC infectious diseases, 2024-08, Vol.24 (1), p.1-9, Article 775

2024

Volltextzugriff (PDF)

Screening for precancerous anal lesions with P16/Ki67 immunostaining in HIV-infected MSM

PloS one, 2017-11, Vol.12 (11), p.e0188851-e0188851

2017

Volltextzugriff (PDF)

Anal Human Papillomavirus Genotype Distribution in HIV-Infected Men Who Have Sex with Men by Geographical Origin, Age, and Cytological Status in a Spanish Cohort

Journal of Clinical Microbiology, 2013-11, Vol.51 (11), p.3512-3520

2013

Volltextzugriff (PDF)

Maraviroc Is Associated with Latent HIV-1 Reactivation through NF-κB Activation in Resting CD4 + T Cells from HIV-Infected Individuals on Suppressive Antiretroviral Therapy

Journal of virology, 2018-05, Vol.92 (9)

2018

Volltextzugriff (PDF)

Correlation between different methods to measure microbial translocation and its association with immune activation in long-term suppressed HIV-1-infected individuals

Journal of acquired immune deficiency syndromes (1999), 2013-10, Vol.64 (2), p.149-153

2013

Volltextzugriff (PDF)

Deep-Sequencing Analysis of the Dynamics of HIV-1 Quasiespecies in Naive Patients during a Short Exposure to Maraviroc

Journal of virology, 2018-06, Vol.92 (11)

2018

Volltextzugriff (PDF)

Raltegravir pharmacokinetics in HIV/HCV-coinfected patients with advanced liver cirrhosis (Child-Pugh C)

Journal of antimicrobial chemotherapy, 2014-02, Vol.69 (2), p.471-475

2014

Volltextzugriff (PDF)

Economic and epidemiologic impact of guidelines for early ART initiation irrespective of CD4 count in Spain

PloS one, 2018-11, Vol.13 (11), p.e0206755-e0206755

2018

Volltextzugriff (PDF)

Intensification of antiretroviral therapy with a CCR5 antagonist in patients with chronic HIV-1 infection: effect on T cells latently infected

PloS one, 2011-12, Vol.6 (12), p.e27864-e27864

2011

Volltextzugriff (PDF)

Virological response to short-course maraviroc monotherapy does not predict viral tropism in HIV-1-infected treatment-naive patients

Journal of antimicrobial chemotherapy, 2014-07, Vol.69 (7), p.1916-1919

2014

Volltextzugriff (PDF)

Economic impact of optimising antiretroviral treatment in human immunodeficiency virus-infected adults with suppressed viral load in Spain, by implementing the grade A-1 evidence recommendations of the 2015 GESIDA/National AIDS Plan

Enfermedades infecciosas y microbiologia clinica, 2018-03, Vol.36 (3), p.157-164

2018

Volltextzugriff (PDF)

Incidence and clearance of anal high-risk human papillomavirus in HIV-positive men who have sex with men: estimates and risk factors

AIDS (London), 2016-01, Vol.30 (1), p.37-44

2016

Volltextzugriff (PDF)

Immune responses to Pneumocystis murina are robust in healthy mice but largely absent in CD40 ligand-deficient mice

Journal of leukocyte biology, 2008-08, Vol.84 (2), p.420-430

2008

Volltextzugriff (PDF)

LEDGF/p75 TATA-Less Promoter Is Driven by the Transcription Factor Sp1

Journal of molecular biology, 2011-11, Vol.414 (2), p.177-193

2011

Volltextzugriff (PDF)

Response to HAART in treatment-naive HIV-infected patients with a prior diagnosis of tuberculosis or other opportunistic infections

Current HIV research, 2011-06, Vol.9 (4), p.229-236

2011

Volltextzugriff (PDF)

Contribution of cabotegravir + rilpivirine long-acting for the treatment of HIV-1 infection

Farmacia hospitalaria, 2022-07, Vol.46 (4), p.208-214

2022

Volltextzugriff (PDF)

Prevalence of Primary Resistance Mutations to Integrase Inhibitors in Treatment-Naïve and -Experienced Patients Infected With B and Non-B HIV-1 Variants

HIV clinical trials, 2013-01, Vol.14 (1), p.10-16

2013

Volltextzugriff (PDF)

Pneumocystis Encodes a Functional S-Adenosylmethionine Synthetase Gene

Eukaryotic Cell, 2008-02, Vol.7 (2), p.258-267

2008

Volltextzugriff (PDF)

Contribución de cabotegravir + rilpivirina de acción prolongada al tratamiento de la infección por VIH-1

Farmacia Hospitalaria, 2022-08, Vol.46 (4), p.208-214

2022

Volltextzugriff (PDF)

Impacto económico asociado a la implementación de las recomendaciones con grado de evidencia A- I del documento de consenso de GeSIDA/PNS (2015) relativas a la optimización del tratamiento antirretroviral en adultos infectados por virus de la inmunodeficiencia humana con carga viral suprimida en España

Enfermedades infecciosas y microbiología clínica, 2018-03, Vol.36 (3), p.157-164

2018

Volltextzugriff (PDF)

Analysis of LEDGF/p75 expression regulation

Retrovirology, 2009-09, Vol.6 (Suppl 2), p.O20-O20, Article O20

2009

Volltextzugriff (PDF)

Economic impact of optimising antiretroviral treatment in human immunodeficiency virus-infected adults with suppressed viral load in Spain, by implementing the grade A-1 evidence recommendations of the 2015 GESIDA/National AIDS Plan

Enfermedades infecciosas y microbiologia clinica (English ed.), 2018-03, Vol.36 (3), p.157-164

2018

Volltextzugriff (PDF)

Topical cidofovir to treat high-grade anal intraepithelial neoplasia in HIV-infected patients: a pilot clinical trial

AIDS (London), 2016-01, Vol.30 (1), p.75-82

2016

Volltextzugriff (PDF)

Impact of low-level viremia on clinical and virological outcomes in treated HIV-1-infected patients

AIDS (London), 2015-01, Vol.29 (3), p.373-383

2015

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Aktive Filter

ThemaMedical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(30)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Prolonged administration of maraviroc reactivates latent HIV in vivo but it does not prevent antiretroviral-free viral rebound

Potential healthcare resource use and associated costs of every 2 month injectable cabotegravir plus rilpivirine long-acting regimen implementation in the Spanish National Healthcare System compared to daily oral HIV treatments

Screening for precancerous anal lesions with P16/Ki67 immunostaining in HIV-infected MSM

Anal Human Papillomavirus Genotype Distribution in HIV-Infected Men Who Have Sex with Men by Geographical Origin, Age, and Cytological Status in a Spanish Cohort

Maraviroc Is Associated with Latent HIV-1 Reactivation through NF-κB Activation in Resting CD4 + T Cells from HIV-Infected Individuals on Suppressive Antiretroviral Therapy

Correlation between different methods to measure microbial translocation and its association with immune activation in long-term suppressed HIV-1-infected individuals

Deep-Sequencing Analysis of the Dynamics of HIV-1 Quasiespecies in Naive Patients during a Short Exposure to Maraviroc

Raltegravir pharmacokinetics in HIV/HCV-coinfected patients with advanced liver cirrhosis (Child-Pugh C)

Economic and epidemiologic impact of guidelines for early ART initiation irrespective of CD4 count in Spain

Intensification of antiretroviral therapy with a CCR5 antagonist in patients with chronic HIV-1 infection: effect on T cells latently infected

Virological response to short-course maraviroc monotherapy does not predict viral tropism in HIV-1-infected treatment-naive patients

Economic impact of optimising antiretroviral treatment in human immunodeficiency virus-infected adults with suppressed viral load in Spain, by implementing the grade A-1 evidence recommendations of the 2015 GESIDA/National AIDS Plan

Incidence and clearance of anal high-risk human papillomavirus in HIV-positive men who have sex with men: estimates and risk factors

Immune responses to Pneumocystis murina are robust in healthy mice but largely absent in CD40 ligand-deficient mice

LEDGF/p75 TATA-Less Promoter Is Driven by the Transcription Factor Sp1

Response to HAART in treatment-naive HIV-infected patients with a prior diagnosis of tuberculosis or other opportunistic infections

Contribution of cabotegravir + rilpivirine long-acting for the treatment of HIV-1 infection

Prevalence of Primary Resistance Mutations to Integrase Inhibitors in Treatment-Naïve and -Experienced Patients Infected With B and Non-B HIV-1 Variants

Pneumocystis Encodes a Functional S-Adenosylmethionine Synthetase Gene

Contribución de cabotegravir + rilpivirina de acción prolongada al tratamiento de la infección por VIH-1

Analysis of LEDGF/p75 expression regulation

Economic impact of optimising antiretroviral treatment in human immunodeficiency virus-infected adults with suppressed viral load in Spain, by implementing the grade A-1 evidence recommendations of the 2015 GESIDA/National AIDS Plan

Topical cidofovir to treat high-grade anal intraepithelial neoplasia in HIV-infected patients: a pilot clinical trial

Impact of low-level viremia on clinical and virological outcomes in treated HIV-1-infected patients

Aktive Filter

Suchergebnisse filtern